Study Stopped
Unable to recruit the anticipated number of subjects for this study
Fertility Assessment in Patients With Klinefelter Syndrome
Non-Invasive Methods to Maximize Fertility in Peri-Pubertal Patients With Klinefelter Syndrome
1 other identifier
observational
6
1 country
2
Brief Summary
Klinefelter syndrome is characterized by primary testicular failure and progressive infertility. The objective of this study is to determine if sperm are present and can be observed in semen samples of adolescent and young adult Klinefelter patients and to determine whether the presence of sperm correlates with physical and/or clinically obtained hormone measures of pubertal development. This study was designed in order to answer the following questions:
- 1.Is it possible to retrieve sperm for cryopreservation from semen samples of adolescent and young adult Klinefelter patients?
- 2.Does the presence of sperm correlate with the physical and/or endocrine measures that are assessed during routine clinical evaluations of pubertal development in the KS patient population?
- 3.If sperm retrieval is possible, what is the optimal age at which sperm retrieval should be attempted?
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for all trials
Started Jan 2016
2 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
May 26, 2015
CompletedFirst Posted
Study publicly available on registry
June 3, 2015
CompletedStudy Start
First participant enrolled
January 7, 2016
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 12, 2017
CompletedStudy Completion
Last participant's last visit for all outcomes
December 12, 2017
CompletedJuly 24, 2018
July 1, 2018
1.9 years
May 26, 2015
July 20, 2018
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Presence of sperm in semen.
Participants will provide at least one semen sample. The presence of sperm will be analyzed. Participants will also be given the opportunity to have their semen analysed for the presence of sperm once a year. Participants will be followed until they reach age 26.
On average once a year until the participant turns 26
Secondary Outcomes (12)
Longitudinal correlation of developmental and endocrine parameters with the presence or absence of sperm in semen samples.
1 time a year for an average of 7.4 years
Correlation of developmental parameters with the presence or absence of sperm in semen samples.
1-2 times a year for an average of 7.4 years
Correlation of developmental parameters with the presence or absence of sperm in semen samples.
1-2 times a year for an average of 7.4 years
Correlation of developmental parameters with the presence or absence of sperm in semen samples.
1-2 times a year for an average of 7.4 years
Correlation of developmental parameters with the presence or absence of sperm in semen samples.
1-2 times a year for an average of 7.4 years
- +7 more secondary outcomes
Interventions
Subjects will be counseled on the impact of KS on the reduced fertility potential, and about providing a semen sample for semen analysis. Semen analysis is the gold standard for fertility preservation in adult patients, but is only rarely considered by post-pubertal adolescent and young adult patients and their families. Only the semen analysis parameters will be used by the study for the comparison with physical and endocrine measures to assess whether spermatogenesis in these patients coincides with pubertal development. All potential frozen samples will be stored for the patient's future use, and samples will not be used for research experiments.
Eligibility Criteria
Adolescent and young adults males who are proven to have Klinefelter Syndrome based on prior chromosome analysis (47,XYY).
You may qualify if:
- males between the ages of 12 and 25
- diagnosed with mosaic or non-mosaic Klinefelter's Syndrome
- having bilaterally descended testes
- not having had a febrile illness within 3 months of enrollment.
You may not qualify if:
- previous treated with gonadotoxic chemotherapeutic or radiation regimen.
- psychological, psychiatric, or other conditions which prevent giving fully informed consent.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (2)
Magee-Womens Hospital
Pittsburgh, Pennsylvania, 15213, United States
Children's Hospital of Pittsburgh of UPMC
Pittsburgh, Pennsylvania, 15224, United States
Biospecimen
Semen samples
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Kyle Orwig, PhD
University of Pittsburgh
Study Design
- Study Type
- observational
- Observational Model
- CASE ONLY
- Time Perspective
- OTHER
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Professor
Study Record Dates
First Submitted
May 26, 2015
First Posted
June 3, 2015
Study Start
January 7, 2016
Primary Completion
December 12, 2017
Study Completion
December 12, 2017
Last Updated
July 24, 2018
Record last verified: 2018-07